Jiangdian Song, Di Dong, Yanqi Huang, Yali Zang, Zaiyi Liu, Jie Tian. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy. In 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2016, Orlando, FL, USA, August 16-20, 2016. pages 1268-1271, IEEE, 2016. [doi]
@inproceedings{SongDHZLT16,
title = {Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy},
author = {Jiangdian Song and Di Dong and Yanqi Huang and Yali Zang and Zaiyi Liu and Jie Tian},
year = {2016},
doi = {10.1109/EMBC.2016.7590937},
url = {http://dx.doi.org/10.1109/EMBC.2016.7590937},
researchr = {https://researchr.org/publication/SongDHZLT16},
cites = {0},
citedby = {0},
pages = {1268-1271},
booktitle = {38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2016, Orlando, FL, USA, August 16-20, 2016},
publisher = {IEEE},
isbn = {978-1-4577-0220-4},
}